| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Dermatology,* University Hospital Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany; the Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan; and the Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
The collapse of major histocompatiblity complex (MHC) class-I-dependent immune privilege can lead to autoimmune disease or fetal rejection. Pragmatic and instructive models are needed to clarify the as yet obscure controls of MHC class I down-regulation in situ, to dissect the principles of immune privilege generation, maintenance, and collapse as well as to develop more effective strategies for immune privilege restoration. Here, we propose that human scalp hair follicles, which are abundantly available and easily studied, are ideally suited for this purpose: interferon-
induces ectopic MHC class I expression in the constitutively MHC class-I-negative hair matrix epithelium of organ-cultured anagen hair bulbs, likely via interferon regulatory factor-1, along with up-regulation of the MHC class I pathway molecules ß2microglobulin and transporter associated with antigen processing (TAP-2). In the first report to identify natural immunomodulators capable of down-regulating MHC class I expression in situ in a normal, neuroectoderm-derived human tissue, we show that ectopic MHC class I expression in human anagen hair bulbs can be normalized by treatment with 
-MSH, IGF-1, or TGF-ß1, all of which are locally generated, as well as by FK506. These agents are promising candidates for immune privilege restoration and for suppressing MHC class I expression where this is clinically desired (eg, in alopecia areata, multiple sclerosis, autoimmune uveitis, mumps orchitis, and fetal or allograft rejection).
This article has been cited by other articles:
 |
|
 |
|
  M. Nakamura, J.-i. Jo, Y. Tabata, and O. Ishikawa Controlled Delivery of T-box21 Small Interfering RNA Ameliorates Autoimmune Alopecia (Alopecia Areata) in a C3H/HeJ Mouse Model Am. J. Pathol., March 1, 2008; 172(3): 650 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M.J. Peters, S. Liotiri, E. Bodo, E. Hagen, T. Biro, P. C. Arck, and R. Paus Probing the Effects of Stress Mediators on the Human Hair Follicle: Substance P Holds Central Position Am. J. Pathol., December 1, 2007; 171(6): 1872 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bodo, A. Kromminga, W. Funk, M. Laugsch, U. Duske, W. Jelkmann, and R. Paus Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin FASEB J, October 1, 2007; 21(12): 3346 - 3354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zoller, P. Gupta, R. Marhaba, M. Vitacolonna, and P. Freyschmidt-Paul Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases J. Leukoc. Biol., July 1, 2007; 82(1): 57 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Giuliani, M Saji, I Bucci, G Fiore, M Liberatore, D S Singer, F Monaco, L D Kohn, and G Napolitano Transcriptional regulation of major histocompatibility complex class I gene by insulin and IGF-I in FRTL-5 thyroid cells. J. Endocrinol., June 1, 2006; 189(3): 605 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bohm, M. Eickelmann, Z. Li, S. W. Schneider, V. Oji, S. Diederichs, G. S. Barsh, A. Vogt, K. Stieler, U. Blume-Peytavi, et al. Detection of Functionally Active Melanocortin Receptors and Evidence for an Immunoregulatory Activity of {alpha}-Melanocyte-Stimulating Hormone in Human Dermal Papilla Cells Endocrinology, November 1, 2005; 146(11): 4635 - 4646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bodo, T. Biro, A. Telek, G. Czifra, Z. Griger, B. I. Toth, A. Mescalchin, T. Ito, A. Bettermann, L. Kovacs, et al. A Hot New Twist to Hair Biology: Involvement of Vanilloid Receptor-1 (VR1/TRPV1) Signaling in Human Hair Growth Control Am. J. Pathol., April 1, 2005; 166(4): 985 - 998. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
